Yes it’s coming . From 500 mil to 1B now. “We are also currently evaluating several potential licensing deals for leronlimab to commercialization companies. We are getting closer to have such agreements in place which will provide CytoDyn non-dilutive funds to execute on our vision,” concluded Dr. Pourhassan. “